Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEGA: Low-Tox vs EOX in advanced gastric cancer
NCT02076594Phase 3Terminated
- Sponsor
- Fondazione Giscad per la Ricerca sui Tumori
- Start
- Jan 2013
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in gastric cancer (GC), sponsored by Fondazione Giscad per la Ricerca sui Tumori. Started Jan 2013; status: terminated.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02076594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076594.